![Andreas Norlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andreas Norlin
Direttore Tecnico/Scientifico/R&S presso
ASCELIA PHARMA AB
Profilo
Andreas L.
Norlin is the founder of Xkout Bioscience AB. Dr. Norlin currently holds the positions of Director at ApoGlyx AB, Director at Desupervised ApS, and Chief Scientific Officer at Ascelia Pharma AB since 2020.
Dr. Norlin completed graduate and doctorate degrees at the University of Lund.
Posizioni attive di Andreas Norlin
| Società | Posizione | Inizio |
|---|---|---|
| ASCELIA PHARMA AB | Direttore Tecnico/Scientifico/R&S | 01/01/2020 |
ApoGlyx AB
 ApoGlyx AB BiotechnologyHealth Technology Engages in research and development in biochemistry | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Andreas Norlin
| Società | Posizione | Fine |
|---|---|---|
Xkout Bioscience AB | Fondatore | - |
Formazione di Andreas Norlin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
19
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ApoGlyx AB
ApoGlyx AB BiotechnologyHealth Technology Engages in research and development in biochemistry | Health Technology |
Ascelia Pharma AB
 Ascelia Pharma AB Pharmaceuticals: MajorHealth Technology Operates as oncology-dedicated drug development company, which develops novel drugs to improve life expectancy | Health Technology |
Xkout Bioscience AB |
